EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial

Sara García-Oreja iD, Francisco Javier Álvaro-Afonso iD, David Navarro-Pérez iD, Diego León-Herce iD, Aroa Tardáguila-García iD, José Luis Lázaro-Martínez iD

Mycoses · 2025

DOI: 10.1111/myc.70121 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Mycoses, 2025. Verfasst von Sara García-Oreja und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Podiatry Clinic, Faculty of Nursing, Physiotherapy and Podiatry, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Antifungal Agents, Chitosan, Ciclopirox, Lasers, Semiconductor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Complutense University and Banco Santander.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antifungals are the standard treatment for onychomycosis. However, oral antifungals present contraindications and potential drug–drug interactions, while topical antifungals suffer from limited efficacy and penetration. Recently, researchers have explored physical therapies, including laser and photodynamic therapy.

Objective

To evaluate the clinical efficacy of combining diode laser therapy with photodynamic therapy and ciclopirox 8% hydroxypropyl chitosan (HPCH) nail lacquer in treating onychomycosis.

Methods

We conducted a randomised controlled clinical trial involving patients with onychomycosis. A total of 26 patients were enrolled and followed for 12 months. Participants received either eight sessions of laser treatment combined with three sessions of photodynamic therapy, or daily treatment with ciclopirox 8% HPCH.

Results

The clinical cure rate was 94.1% in the group treated with laser and photodynamic therapy, compared to 53.3% in the group treated with ciclopirox 8% HPCH ( p = 0.008). All patients who achieved clinical cure with either treatment also reached mycologic and complete cure, with a rate of 100%. The average time to healing was significantly shorter for the group receiving laser and photodynamic therapy (3.6 ± 1.2 months) than for those treated with ciclopirox 8% HPCH nail lacquer (9.2 ± 1.6 months) ( p < 0.001). In the laser and photodynamic therapy group, adverse events, specifically subungual hematoma and blisters, occurred in 11.4% of patients, with a recurrence rate of 33.3%. No adverse events or recurrence were observed in patients treated with ciclopirox 8% HPCH.

Conclusions

Treatment of onychomycosis using diode laser and photodynamic therapy results in higher clinical cure rates and shorter healing times compared to the reference treatment with 8% ciclopirox HPCH. Trial Registration ClinicalTrials.gov identifier: NCT05809297

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsChitosanCiclopiroxLasers, SemiconductorOnychomycosisPhotochemotherapyPyridonesAdultAgedFemaleHumansMaleMiddle AgedYoung AdultLacquerNailsTreatment Outcome

Stichwörter der Autor:innen

ciclopiroxlaseronychomycosisphotodynamic therapytoluidinetopical antifungaltreatment

Substanzen

Antifungal AgentsChitosanCiclopiroxPyridones

Autor:innen und Institutionen

  • University Podiatry Clinic, Faculty of Nursing, Physiotherapy and Podiatry, Complutense University of Madrid, Madrid, Spain.
  • Diabetic Foot Unit, University Podiatry Clinic, Faculty of Nursing, Physiotherapy and Podiatry, Complutense University of Madrid, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), Madrid, Spain.

ORCID-Profile: Sara García-Oreja, Francisco Javier Álvaro-Afonso, David Navarro-Pérez, Diego León-Herce, Aroa Tardáguila-García, José Luis Lázaro-Martínez

Förderung

  • Complutense University and Banco Santander

Zitieren

APA

García-Oreja, S., Álvaro-Afonso, F. J., Navarro-Pérez, D., León-Herce, D., Tardáguila-García, A., & Lázaro-Martínez, J. L. (2025). Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial. Mycoses. https://doi.org/10.1111/myc.70121

Vancouver

García-Oreja S, Álvaro-Afonso FJ, Navarro-Pérez D, León-Herce D, Tardáguila-García A, Lázaro-Martínez JL. Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial. Mycoses. 2025. doi:10.1111/myc.70121

BibTeX
@article{GarcaOreja2025,
  author = {García-Oreja, Sara and Álvaro-Afonso, Francisco Javier and Navarro-Pérez, David and León-Herce, Diego and Tardáguila-García, Aroa and Lázaro-Martínez, José Luis},
  title = {Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial},
  journal = {Mycoses},
  year = {2025},
  doi = {10.1111/myc.70121}
}
Kostenlos starten →